Olema Pharmaceuticals Inc — Cash Flow (NASDAQ:OLMA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities -50.69 M-82.06 M-83.73 M-104.35 M -134.67 M Cash from investing activities -275.44 M91.48 M-4.85 M-93.53 M -108 M Cash from financing activities 1.39 M476 K133.41 M268.82 M 242.04 M Free cash flow -52.27 M-82.43 M-83.73 M-104.51 M -134.67 M

News

Olema : pertes croissantes avant des données clés attendues

Olema earnings on deck: Biotech faces widening loss ahead of key data

Olema Pharmaceuticals, Inc. (OLMA) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

Olema Pharmaceuticals, Inc. (OLMA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

Stifel initiates Olema Pharmaceuticals stock with Buy rating, $48 target

Le cours de l’action Olema Pharmaceuticals chute après l’annonce du départ du CFO

Olema Pharmaceuticals stock falls after CFO announces departure

Olema Pharmaceuticals CFO Shane Kovacs departs, CEO assumes interim finance role

Le directeur financier d’Olema Oncology, Shane Kovacs, quittera ses fonctions après six ans

Olema Oncology CFO Shane Kovacs to depart after six-year tenure

Harmon Cyrus, directeur d’Olema, vend des actions pour 268.800€

Harmon Cyrus, director at Olema, sells $268,800 in stock